Encyclopedia of Nanotechnology

Living Edition
| Editors: Bharat Bhushan

Use of Nanotechnology in Pregnancy

  • Achini K. VidanapathiranaEmail author
Living reference work entry
DOI: https://doi.org/10.1007/978-94-007-6178-0_100902-1



This entry examines the applications of nanotechnology during pregnancy (current, research, and potential applications), the unique pregnancy-related characteristics that relate in the application of nanoscale materials, and the concerns on maternal/fetal well-being.


Nanotechnology is being progressively researched, and nanoscale products are manufactured for various engineering devices, consumer products, diagnostic, and therapeutic applications to be utilized during different human life stages including pregnancy. Pregnancy is a life stage combined with the unique physiological changes and characteristic remodeling of maternal tissues supporting the growth and development of the fetus(es). As a result of these adaptive mechanisms to support fetal growth, the drug metabolism, particle...


Gold Nanoparticles Fetal Tissue Placental Barrier Nanoparticle Exposure Gestational Stage 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in to check access.


  1. 1.
    Yu, J., et al.: Comparative study on contraceptive efficacy and clinical performance of the copper/low-density polyethylene nanocomposite IUD and the copper T220C IUD. Contraception 78, 319–323 (2008)CrossRefGoogle Scholar
  2. 2.
    Menezes, V., Malek, A., Keelan, J.A.: Nanoparticulate drug delivery in pregnancy: placental passage and fetal exposure. Curr. Pharm. Biotechnol. 12, 731–742 (2011)CrossRefGoogle Scholar
  3. 3.
    Kaitu’u-Lino, T.J., et al.: Targeted nanoparticle delivery of doxorubicin into placental tissues to treat ectopic pregnancies. Endocrinology 154, 911–919 (2013)CrossRefGoogle Scholar
  4. 4.
    Sumner, S.C., Fennell, T.R., Snyder, R.W., Taylor, G.F., Lewin, A.H.: Distribution of carbon-14 labeled C60 ([14C]C60) in the pregnant and in the lactating dam and the effect of C60 exposure on the biochemical profile of urine. J. Appl. Toxicol. 30, 354–360 (2010)Google Scholar
  5. 5.
    Qi, W., et al.: Damaging effects of multi-walled carbon nanotubes on pregnant mice with different pregnancy times. Sci. Rep. 4, 4352 (2014)Google Scholar
  6. 6.
    Jo, E., et al.: Exposure to zinc oxide nanoparticles affects reproductive development and biodistribution in offspring rats. J. Toxicol. Sci. 38, 525–530 (2013)CrossRefGoogle Scholar
  7. 7.
    Melnik, E.A., et al.: Transfer of silver nanoparticles through the placenta and breast milk during in vivo experiments on rats. Acta Nat. 5, 107–115 (2013)Google Scholar
  8. 8.
    Buerki-Thurnherr, T., von Mandach, U., Wick, P.: Knocking at the door of the unborn child: engineered nanoparticles at the human placental barrier. Swiss Med. Wkly. 142, 3559 (2012)Google Scholar
  9. 9.
    Yang, H., et al.: Effects of gestational age and surface modification on materno-fetal transfer of nanoparticles in murine pregnancy. Sci. Rep. 2, 847 (2012)Google Scholar
  10. 10.
    Kulvietis, V., Zalgeviciene, V., Didziapetriene, J., Rotomskis, R.: Transport of nanoparticles through the placental barrier. Tohoku J. Exp. Med. 225, 225–234 (2011)CrossRefGoogle Scholar
  11. 11.
    Ema, M., Kobayashi, N., Naya, M., Hanai, S., Nakanishi, J.: Reproductive and developmental toxicity studies of manufactured nanomaterials. Reprod. Toxicol. 30, 343–352 (2010)CrossRefGoogle Scholar
  12. 12.
    Wick, P., et al.: Barrier capacity of human placenta for nanosized materials. Environ. Health Perspect. 118, 432–436 (2010)CrossRefGoogle Scholar
  13. 13.
    Yamashita, K., et al.: Silica and titanium dioxide nanoparticles cause pregnancy complications in mice. Nat. Nanotechnol. 6, 321–328 (2011)CrossRefGoogle Scholar
  14. 14.
    Zalgeviciene, V., Kulvietis, V., Bulotiene, D., Didziapetriene, J., Rotomskis, R.: The effect of nanoparticles in rats during critical periods of pregnancy. Medicina (Kaunas) 48, 256–264 (2012)Google Scholar
  15. 15.
    Stapleton, P.A., et al.: Maternal engineered nanomaterial exposure and fetal microvascular function: does the Barker hypothesis apply? Am. J. Obstet. Gynecol. 209, 227 (2013)CrossRefGoogle Scholar
  16. 16.
    Vidanapathirana, A.K., et al.: PVP formulated fullerene (C60) increases Rho-kinase dependent vascular tissue contractility in pregnant Sprague Dawley rats. Reprod. Toxicol. 49, 86–100 (2014)CrossRefGoogle Scholar
  17. 17.
    Vidanapathirana, A.K., et al.: Vascular tissue contractility changes following late gestational exposure to multi-walled carbon nanotubes or their dispersing vehicle in Sprague Dawley rats. J. Nanomed. Nanotech. 5(3), 1000201 (2014)Google Scholar
  18. 18.
    Juch, H., Nikitina, L., Debbage, P., Dohr, G., Gauster, M.: Nanomaterial interference with early human placenta: sophisticated matter meets sophisticated tissues. Reprod. Toxicol. 41, 73–79 (2013)CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media Dordrecht 2014

Authors and Affiliations

  1. 1.Australian Research Council (ARC) Centre for Nanoscale BiophotonicsUniversity of AdelaideAdelaide, SAAustralia
  2. 2.Heart HealthSouth Australian Health and Medical Research Institute, AdelaideSAAustralia